Atlas Trials

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Clinical trial NCT01266447 · COMPLETED

Trial details

NCT number
NCT01266447
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell CarcinomaRecurrent Cervical CarcinomaStage III Cervical CancerStage IVA Cervical CancerStage IVB Cervical Cancer
Start date
2011-02-01
Primary completion
2016-01-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.